TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones
Thidarat Kongkaew, Rattapoom Thaiwong, Suparat Tudsamran, Thitiya Sae‐jung, Panjana Sengprasert, Apichai Vasuratna, Koramit Suppipat, Rangsima Reantragoon
Topics & Concepts
Tumor-infiltrating lymphocytesCD28CD8T-cell receptorAdoptive cell transferBiologyImmunologyCytotoxic T cellT cellCancer researchCD3StimulationImmunotherapyImmune systemEndocrinologyIn vitroBiochemistryImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersCAR-T cell therapy research